Low-dose nivolumab (Opdivo) plus lenalidomide (Revlimid) yielded a promising response with a favorable safety profile in patients with classical Hodgkin lymphoma (cHL), according to a single-arm phase ...

Rilzabrutinib (Wayrilz; Sanofi) may improve immune thrombocytopenia (ITP) outcomes, enable early intervention, and enhance patient quality of life.

Interstitial lung disease was a common adverse event with 10 of the 15 FDA-approved antibody-drug conjugates, according to data from FAERS.

Post-CAR T infection prophylaxis should follow European Hematology Association/European Society for Blood and Marrow ...

ISLAMABAD, Sep 29 (APP): Chief Traffic Officer (CTO) Capt (retd) Hamza Humayun on Monday visited the Pakistan Institute of ...

An Islamabad Traffic Police (ITP) officer, ASI Saleem, was seriously injured after being hit by a Honda City car while on ...

Researchers sought to determine whether CD19/CD20 dual-targeted CAR-T therapy would yield better results compared with standard CD19-directed CAR-T therapy among patients with R/R DLBCL.

ITF Therapeutics LLC, the U.S. affiliate of Italfarmaco, today announced that results on givinostat for the treatment of Duchenne muscular dystrophy (DMD) are being presented at the 2025 Neuromuscular ...

There’s been another detour in tolebrutinib’s path to market, with developer Sanofi revealing that the US Food and Drug ...

When you're facing metastatic breast cancer, the questions can pile up fast. Here are some clear answers to guide you.

DelveInsight's,“ Immune Thrombocytopenia Pipeline Insight 2025 ” report provides comprehensive insights about 30+ companies and 30+ pipeline drugs in Immune Thrombocytopenia pipeline landscape. It ...

I’ve never had an illness or sickness before that took so many medical professionals to approve medication. Having immune thrombocytopenia (ITP) is a rare disease that many people are not aware of.